These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11343670)

  • 21. Declining testicular function in aging men.
    Tenover JS
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of testosterone in plasma proteins during replacement therapy with testosterone enanthate in patients suffering from hypogonadism.
    Demisch K; Nickelsen T
    Andrologia; 1983; 15 Spec No():536-41. PubMed ID: 6666861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
    Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
    Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease.
    Tan RS; Pu SJ
    Aging Male; 2003 Mar; 6(1):13-7. PubMed ID: 12809076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
    Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
    BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ; Wang C;
    J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men.
    Leifke E; Körner HC; Link TM; Behre HM; Peters PE; Nieschlag E
    Eur J Endocrinol; 1998 Jan; 138(1):51-8. PubMed ID: 9461316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone supplementation therapy as a treatment of hypogonadism.
    Schmidtova E; Kelemenova S; Ostatnikova D
    Bratisl Lek Listy; 2009; 110(12):765-72. PubMed ID: 20196470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis.
    Hajjar RR; Kaiser FE; Morley JE
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3793-6. PubMed ID: 9360543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Utility of Sex Hormone-Binding Globulin in Hypogonadism and Infertile Males.
    Ring J; Welliver C; Parenteau M; Markwell S; Brannigan RE; Köhler TS
    J Urol; 2017 May; 197(5):1326-1331. PubMed ID: 28087298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgens and the ageing male.
    Juul A; Skakkebaek NE
    Hum Reprod Update; 2002; 8(5):423-33. PubMed ID: 12398223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone and body functions.
    Köhn FM
    Aging Male; 2006 Dec; 9(4):183-8. PubMed ID: 17178552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and risks of testosterone therapy in older men.
    Cardona Attard C; Fava S
    Minerva Urol Nefrol; 2019 Jun; 71(3):217-229. PubMed ID: 30700083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.
    Leder BZ; Finkelstein JS
    Osteoporos Int; 2005 Dec; 16(12):1487-94. PubMed ID: 15856361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
    Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.